Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 126 entries
View as:

A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06162351 Org: User:
Start: 04/17/24 End: 04/17/27 Due: 04/17/28

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04823377 Org: User:
Start: 09/24/21 End: 09/23/27 Due: 09/23/28

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Phase: N/A Priority: Normal
NCT ID: NCT01217398 Org: User:
Start: 10/31/09 End: - Due: -

Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.

Phase: N/A Priority: Normal
NCT ID: NCT02857699 Org: User:
Start: 04/30/14 End: 06/30/17 Due: 06/30/18

Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT03964116 Org: User:
Start: 12/07/18 End: 01/25/24 Due: 01/25/25

Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4

Phase: N/A Priority: Normal
NCT ID: NCT05088395 Org: User:
Start: 05/19/22 End: 06/01/31 Due: 06/01/32

Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05955170 Org: User:
Start: 12/19/23 End: 12/19/28 Due: 12/19/29

A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)

Phase: N/A Priority: Normal
NCT ID: NCT02831634 Org: User:
Start: 06/09/16 End: 03/01/18 Due: 03/01/19

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology

Phase: N/A Priority: Normal
NCT ID: NCT05781295 Org: User:
Start: 01/19/24 End: 07/23/28 Due: 07/23/29

Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03690440 Org: User:
Start: 06/15/18 End: 12/31/18 Due: 12/31/19

Consultation to Announce the End of Chemotherapy and Specific Treatments in an Outpatient Setting: Evaluation of the Psychological Impact and Information Exchange.

Phase: N/A Priority: Normal
NCT ID: NCT05293925 Org: User:
Start: 01/27/22 End: 07/25/23 Due: 07/25/24

A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01771458 Org: User:
Start: 10/31/12 End: 12/31/16 Due: 12/31/17

Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05634395 Org: User:
Start: 02/17/23 End: 05/19/26 Due: 05/19/27

Transcutaneous Breast Cancer Diagnosis by Canine Odorology

Phase: N/A Priority: Normal
NCT ID: NCT04217109 Org: User:
Start: 02/03/20 End: 04/25/23 Due: 04/25/24

Chlorhydrate of Ropivacaine and Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00370240 Org: User:
Start: 09/30/06 End: 11/30/08 Due: 11/30/09

Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT05141383 Org: User:
Start: 05/04/22 End: 09/03/24 Due: 09/03/25

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma

Phase: N/A Priority: Normal
NCT ID: NCT04731610 Org: User:
Start: 12/28/21 End: 12/28/29 Due: 12/28/30

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03703557 Org: User:
Start: 07/25/18 End: 09/20/20 Due: 09/20/21

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

Phase: N/A Priority: Normal
NCT ID: NCT04424719 Org: User:
Start: 07/08/20 End: 07/07/37 Due: 07/07/38

AsiDNA Children, Adolescents and Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT05394558 Org: User:
Start: 05/27/22 End: 09/20/23 Due: 09/20/24

Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis

Phase: N/A Priority: Normal
NCT ID: NCT06659705 Org: User:
Start: 09/30/25 End: 01/30/30 Due: 01/30/31

Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03964298 Org: User:
Start: 11/30/16 End: 12/31/19 Due: 12/31/20

PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02438761 Org: User:
Start: 08/31/15 End: 04/23/18 Due: 04/23/19

Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave),

Phase: N/A Priority: Normal
NCT ID: NCT02834494 Org: User:
Start: 02/22/16 End: 09/09/20 Due: 09/09/21

Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

Phase: N/A Priority: Normal
NCT ID: NCT02839473 Org: User:
Start: 03/31/10 End: 07/31/14 Due: 07/31/15